Royal Bank Of Canada Analysts Give Endo International PLC (ENDP) a $9.00 Price Target

Royal Bank Of Canada set a $9.00 price target on Endo International PLC (NASDAQ:ENDP) (TSE:ENL) in a research note released on Tuesday. The brokerage currently has a hold rating on the stock.

A number of other brokerages also recently weighed in on ENDP. Oppenheimer Holdings, Inc. reaffirmed a hold rating on shares of Endo International PLC in a research note on Sunday, July 23rd. BidaskClub raised shares of Endo International PLC from a sell rating to a hold rating in a research note on Wednesday, July 19th. Zacks Investment Research downgraded shares of Endo International PLC from a hold rating to a sell rating in a research note on Tuesday, July 11th. Deutsche Bank AG lowered their target price on shares of Endo International PLC from $18.00 to $15.00 and set a buy rating on the stock in a research note on Friday, July 7th. Finally, Cantor Fitzgerald set a $9.00 target price on shares of Endo International PLC and gave the company a hold rating in a research note on Tuesday, August 8th. Three research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and five have given a buy rating to the stock. Endo International PLC currently has a consensus rating of Hold and an average target price of $12.64.

Shares of Endo International PLC (NASDAQ:ENDP) opened at 7.72 on Tuesday. The company’s market capitalization is $1.72 billion. The company’s 50 day moving average is $8.52 and its 200 day moving average is $10.43. Endo International PLC has a one year low of $7.41 and a one year high of $21.87.

Endo International PLC (NASDAQ:ENDP) (TSE:ENL) last announced its earnings results on Tuesday, August 8th. The company reported $0.93 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.19. The business had revenue of $875.73 million for the quarter, compared to the consensus estimate of $832.66 million. Endo International PLC had a negative net margin of 126.93% and a positive return on equity of 37.58%. Endo International PLC’s quarterly revenue was down 4.9% on a year-over-year basis. During the same period last year, the firm posted $0.86 earnings per share. Equities research analysts predict that Endo International PLC will post $3.52 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Royal Bank Of Canada Analysts Give Endo International PLC (ENDP) a $9.00 Price Target” was first published by BBNS and is owned by of BBNS. If you are reading this story on another website, it was illegally stolen and reposted in violation of US and international copyright legislation. The correct version of this story can be accessed at https://baseballnewssource.com/markets/royal-bank-of-canada-analysts-give-endo-international-plc-endp-a-9-00-price-target/1720865.html.

In related news, CEO Paul Campanelli purchased 6,500 shares of the business’s stock in a transaction that occurred on Monday, August 14th. The shares were acquired at an average price of $7.71 per share, for a total transaction of $50,115.00. Following the completion of the acquisition, the chief executive officer now directly owns 213,620 shares in the company, valued at approximately $1,647,010.20. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Terrance J. Coughlin purchased 20,000 shares of the business’s stock in a transaction that occurred on Thursday, August 10th. The stock was bought at an average price of $7.70 per share, for a total transaction of $154,000.00. Following the acquisition, the chief operating officer now owns 181,369 shares of the company’s stock, valued at $1,396,541.30. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 36,000 shares of company stock worth $279,460. 0.50% of the stock is currently owned by company insiders.

A number of large investors have recently added to or reduced their stakes in the stock. HL Financial Services LLC boosted its holdings in Endo International PLC by 1.0% in the second quarter. HL Financial Services LLC now owns 52,800 shares of the company’s stock valued at $590,000 after acquiring an additional 500 shares in the last quarter. Amalgamated Bank boosted its holdings in Endo International PLC by 2.0% in the first quarter. Amalgamated Bank now owns 32,357 shares of the company’s stock valued at $361,000 after acquiring an additional 619 shares in the last quarter. Meeder Asset Management Inc. boosted its holdings in Endo International PLC by 1.4% in the second quarter. Meeder Asset Management Inc. now owns 48,699 shares of the company’s stock valued at $544,000 after acquiring an additional 677 shares in the last quarter. Capstone Asset Management Co. boosted its holdings in Endo International PLC by 3.1% in the second quarter. Capstone Asset Management Co. now owns 32,035 shares of the company’s stock valued at $358,000 after acquiring an additional 960 shares in the last quarter. Finally, Arizona State Retirement System boosted its holdings in Endo International PLC by 1.5% in the second quarter. Arizona State Retirement System now owns 83,700 shares of the company’s stock valued at $935,000 after acquiring an additional 1,200 shares in the last quarter. Institutional investors and hedge funds own 90.71% of the company’s stock.

Endo International PLC Company Profile

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.

Analyst Recommendations for Endo International PLC (NASDAQ:ENDP)

Receive News & Ratings for Endo International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International PLC and related companies with our FREE daily email newsletter.

 


Latest News

Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Yankees to Send Masahiro Tanaka Against Astros in Game 1


Leave a Reply

 
© 2006-2017 BBNS.